RAQUALIA PHARMA INC revenue for the last year amounted to 3.11 B JPY, the most of which — 3.11 B JPY — came from its highest performing source at the moment, Pharmaceutical, the year earlier bringing 1.90 B JPY. The greatest contribution to the revenue figure was made by Asia — last year it brought RAQUALIA PHARMA INC 1.26 B JPY, and the year before that — 800.79 M JPY.